Application 050582
- Type
- NDA
- Sponsor
- MAYNE PHARMA INTL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DORYX | DOXYCYCLINE HYCLATE | CAPSULE, DELAYED RELEASE;ORAL | EQ 100MG BASE | Yes | No |
| 002 | DORYX | DOXYCYCLINE HYCLATE | CAPSULE, DELAYED RELEASE;ORAL | EQ 75MG BASE | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050582-001 | DORYX | DOXYCYCLINE HYCLATE | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | |
| N050582-002 | DORYX | DOXYCYCLINE HYCLATE | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N050582-001 | DORYX | EQ 100MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 1985-07-22 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N050582-002 | DORYX | EQ 75MG BASE | CAPSULE, DELAYED RELEASE / ORAL | RLD | 2001-08-13 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | NuCare Pharmaceuticals,Inc. | 88012cf8-509b-84cf-e053-2a95a90af3bc | 2024-06-14 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | a2df1a8c-7a22-462d-830a-04e6ac5a912f | 2024-04-28 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | 1dd7a94e-bf29-4f07-9476-ac8d1f9ab565 | 2024-04-28 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | 4164f6b7-5ebd-4f5f-a536-9a37b2e0562c | 2024-04-28 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | a84d7562-08bf-417f-a599-ba0d17c55232 | 2024-04-25 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Proficient Rx LP | e38f3cd2-47e5-438f-bbe3-50b578360f74 | 2024-03-01 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Lupin Pharmaceuticals,Inc. | b752ea66-3144-4f78-96fe-a5f4d92740a7 | 2024-01-30 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | NuCare Pharmaceuticals,Inc. | 0fdc3d87-8819-4c2c-e063-6394a90a687b | 2024-01-26 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | e567b431-53fe-4e27-9b05-bf6eeb8abb51 | 2023-12-11 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 44ac5de1-c0c6-4d58-9a49-b2dae60ea921 | 2023-04-10 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 6e587d8d-1a82-4dfa-acea-88704d408f2f | 2023-01-30 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 24c8472a-dd07-4f84-8bea-20a3f178d119 | 2023-01-27 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | ec4535a1-69f0-40a2-bcba-11afc75c721d | 2023-01-27 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | dd7672c9-b10f-4ea1-9000-ef3e3faa10db | 2022-09-01 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | 86c1f165-af79-4f01-ab61-3bdbce24cd0d | 2022-04-01 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | 2993ac3d-0ec4-4230-858e-9fd00063cf57 | 2022-04-01 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | 3303b423-b270-495b-9360-e43144fcf6f2 | 2021-04-01 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Sonoma Pharmaceuticals, Inc. | 4fa26176-a730-48ed-9659-e2f64212f418 | 2018-05-23 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Novel Laboratories, Inc. | 25a92544-1421-4ccb-a49c-11742851f214 | 2018-03-12 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
| Acticlate CAP | DOXYCYCLINE HYCLATE | Aqua Pharmaceuticals | 5e96d473-63dd-4446-88cf-eef2cd3339f0 | 2017-11-28 | Warnings, Adverse reactions | DOXYCYCLINE HYCLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 81851 | SUPPL | 2025-04-08 |
| 81806 | SUPPL | 2025-04-02 |
| 62032 | SUPPL | 2020-03-04 |
| 62024 | SUPPL | 2020-03-04 |
| 52511 | SUPPL | 2018-02-08 |
| 52506 | SUPPL | 2018-02-08 |
| 39002 | SUPPL | 2015-09-04 |
| 30112 | SUPPL | 2015-09-04 |
| 30111 | SUPPL | 2011-03-24 |
| 39001 | SUPPL | 2008-02-14 |
| 7844 | SUPPL | 2008-02-13 |
| 39000 | SUPPL | 2005-05-17 |
| 7843 | SUPPL | 2005-05-17 |
| 30110 | SUPPL | 2004-02-27 |
| 30109 | SUPPL | 2003-06-08 |
| 7842 | SUPPL | 2002-06-18 |